Targeting DUSP6 protein to prevent breast cancer recurrence

FHS
June 19, 2024
6:22 am

Treatment outcomes for breast cancer have become better over the years, but proportion of breast cancers still recur even after long periods without signs of cancer remaining dormant in the body.

EMA starts review into hair loss drugs about potential link to suicidal thoughts – Pharmaceutical Technology

Androgenic alopecia is a hair loss condition that primarily affects the top and front of the scalp. Credit: PippiLongstocking via Shutterstock. The European Medicines Agency

October 7, 2024

Readers respond to essays on philanthropy and nursing schools, opioid overdoses, and more

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care

July 20, 2024

Lawmakers urge U.S. Patent Office and drugmakers to correct patent mistakes

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling mistakes in disclosing patent terms,

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.